title: Prevalence and molecular characterization of Streptococcus pneumoniae serotype 6C causing invasive disease in Gipuzkoa, northern Spain, 1990-2009.
abstract: The recently discovered pneumococcus serotype 6C was responsible for ten of the 1,530 invasive isolates studied between 1990 and 2009. These ten isolates belonged to seven sequence types (STs) and were isolated only from adult patients: six with bacteremia, three with meningitis, and one with peritonitis. All isolates but one were fully penicillin-susceptible.
authors.affiliation: Servicio de Microbiología, Hospital Donostia, Paseo Dr. Beguiristain s/n, San Sebastián, Spain.
authors.forename: J M
authors.initials: JM
authors.lastname: Marimon
authors.forename: M
authors.initials: M
authors.lastname: Ercibengoa
authors.forename: M
authors.initials: M
authors.lastname: Alonso
authors.forename: G
authors.initials: G
authors.lastname: García-Medina
authors.forename: E
authors.initials: E
authors.lastname: Pérez-Trallero
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D016470:Bacteremia / Q000453:epidemiology / Q000382:microbiology; D015373:Bacterial Typing Techniques; D002648:Child; D002675:Child, Preschool; D016172:DNA Fingerprinting; D004269:DNA, Bacterial / Q000737:chemistry / Q000235:genetics; D005260:Female; D005838:Genotype; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D016920:Meningitis, Bacterial / Q000453:epidemiology / Q000382:microbiology; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010406:Penicillins / Q000494:pharmacology; D011008:Pneumococcal Infections / Q000453:epidemiology* / Q000382:microbiology*; D015995:Prevalence; D017422:Sequence Analysis, DNA; D012703:Serotyping; D013030:Spain / Q000453:epidemiology; D013296:Streptococcus pneumoniae / Q000145:classification* / Q000302:isolation & purification*; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents; D004269:DNA, Bacterial; D010406:Penicillins
references.citation: J Clin Microbiol. 2009 Feb;47(2):472-4
references.pmid: 19073873
references.citation: Int J Antimicrob Agents. 2008 Nov;32 Suppl 1:S66-70
references.pmid: 18723328
references.citation: J Clin Microbiol. 2007 Apr;45(4):1225-33
references.pmid: 17267625
references.citation: J Antimicrob Chemother. 2004 Apr;53(4):620-5
references.pmid: 14973156
references.citation: J Clin Microbiol. 2009 Aug;47(8):2470-4
references.pmid: 19535528
references.citation: J Clin Microbiol. 2009 Mar;47(3):554-9
references.pmid: 19116353
references.citation: J Infect Dis. 2009 Nov 1;200(9):1375-80
references.pmid: 19803727
references.citation: Diagn Microbiol Infect Dis. 2009 Oct;65(2):112-5
references.pmid: 19709842
references.citation: J Clin Microbiol. 2009 Jan;47(1):64-72
references.pmid: 18971356
references.citation: J Infect Dis. 2008 Dec 15;198(12):1818-22
references.pmid: 18983249
references.citation: Vaccine. 2008 Jan 24;26(4):449-50
references.pmid: 18093702
references.citation: Microbiology (Reading). 2010 Feb;156(Pt 2):555-560
references.pmid: 19942663